SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Summer Interns

IP-Watch interns talk about their Geneva experience in summer 2013. 2:42.

Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Quantitative Analysis Of Contributions To NETMundial Meeting

A quantitative analysis of the 187 submissions to the April NETmundial conference on the future of internet governance shows broad support for improving security, ensuring respect for privacy, ensuring freedom of expression, and globalizing the IANA function, analyst Richard Hill writes.


Latest Comments
  • Why should anyone care what James Anaya thinks? In... »
  • If this goes ahead, as the EU will "speak" for all... »

  • For IPW Subscribers

    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >


    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >

    WHO Initiative On Poor Quality Medicines Heads To Board Next Week

    Published on 15 January 2014 @ 12:41 pm

    By , Intellectual Property Watch

    World Health Organization member governments have been working for several years to agree on ways to prevent the spread of dangerous and misleading substandard and fake medical products. Now, they seem to be moving in the direction of concrete action.  

    Members working on the issue have adopted a “non-exhaustive” list identifying “actions, activities and behaviours” that result in such products, according to a report of the second meeting of the so-called Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit Medical Products, which took place on 28-29 November.

    They also have a workplan on these issues, and have drafted a budget of nearly US$13 million to carry out the range of workplan objectives.

    These WHO efforts come in the context of other recent initiatives, including one announced this week at the UN Office of Drug Control tying counterfeiting to organised crime (IPW, Public Health, 14 January 2014), and an industry-government-international organisation initiative called “Fight the Fakes” (IPW, Public Health, 26 November 2013). There also is an initiative on a medicines quality database highlighted [pdf] in the January edition of the WHO Bulletin.

    WHO Report

    The WHO director general’s office has submitted its report on SSFFC – as the issue is called at WHO – to the Executive Board, which will meet from 20-25 January.

    The WHO report includes: the November meeting report; the actions, activities and behaviours list; the workplan; and the budget. The Board document on SSFFC dated 3 January is numbered EB134/25. Documents for the 134th Executive Board are here.

    The list of actions contains 11 activities that can lead to poor quality or fake products. Examples are manufacturing products in unauthorised establishments, changing packaging or extending expiration dates, substituting contents, and any aspect of distribution without compliance to regulations.

    The aim of the list is to ensure that only medical products meeting national or regional regulatory requirements are manufactured, imported, distributed and supplied.

    The workplan contains eight multi-layered actions, including: strengthening regulatory authorities and quality control laboratories and increasing their collaboration; awareness-raising; transparent consultation with stakeholders; boosting of the supply chain; and collaboration on surveillance and monitoring.

    It also calls for work with other areas of WHO that “address access to quality, safe, efficacious and affordable medical products, including but not limited to the supply and use of generic medical products, which should complement measures for the prevention and control of SSFFC medical products.”

    Argentina and India, which made additional proposals, are going to lead technical discussions on their proposals on an electronic platform hosted by the WHO secretariat, according to the report from the November Member State Mechanism meeting.

    The report says that consideration was given to a proposal from Argentina that would develop recommendations for health authorities to “detect and deal with” activities that lead to SSFFC products.

    And a proposal by India was considered that addressed activities that fall outside the mandate of the mechanism.

    Funding Gap

    The November meeting also endorsed the budget, after being “highly concerned by the funding gap at this stage.” They “strongly” recommended the Executive Board request the director general to give a comprehensive update to the May World Health Assembly on the financing of the workplan, and encourage member states and other WHO donors to consider funding the workplan.

    The budget lays out estimated costs for each of the 8 objectives, ranging from less than $1 million to about $3 million. But it says that currently, the initiative only has about $500,000 for each of 2014 and 2015, or about 10 percent of the overall budget.

    Governance

    On governance, a sticky issue in the past, it was agreed to continue a rotating chairmanship of the Mechanism and steering committee among the numerous vice-chairs. The November meeting was chaired by Nigeria, which will continue through the May 2014 World Health Assembly. Then the chair will be one of the vice-chairs from the Americas. According to a list in the report, there are representatives from Argentina and the United States from that region. Also, in meetings, vice-chairs will act on behalf of their governments rather than in their personal capacity.

    Finally, the report refers to consideration by the mechanism of topics proposed for discussion by the Open-ended Working Group and the Steering Committee. These were on misleading advertising, corruption and conflict of interest, and lack of effective labelling.

    Next SSFFC Group Meeting: October 2014

    The WHO steering committee on the SSFFC issue was asked to prioritise proposals for implementation of the workplan, to be reviewed by the third meeting of the Member State Mechanism, which is planned for the week of 27 October 2014.

    Background

    The WHO Member State Mechanism on SSFFCs was established at the May 2012 World Health Assembly but started slowly. The mechanism is mandated to look at the problem from a health perspective, and not consider intellectual property or trade. The expert group held its first meeting in Buenos Aires in November 2012 and agreed on a roadmap (IPW, WHO, 22 November 2012), but disagreement over selection of a chair slowed progress. It was proposed by Brazil to have a rotating chair, which was accepted in a breakthrough at the May 2013 Assembly (IPW, WHO, 26 May 2013).

    William New may be reached at wnew@ip-watch.ch.

     

    Comments

    1. WHO Board To Discuss Relationship With Industry, Organisations | Intellectual Property Watch says:

      […] and have drafted a budget of nearly US$13 million to carry out the range of workplan objectives (IPW, WHO, 15 January 2014). […]


    Leave a Reply

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website. By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

    By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

    1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

    2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

    3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

    4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

    5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

    6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

    7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

    8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

    9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

     

     
    Your IP address is 54.204.217.249